Elicio Therapeutics, Inc. Annual Revenues in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Elicio Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2020 to 2022.
  • Elicio Therapeutics, Inc. Revenues for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
  • Elicio Therapeutics, Inc. Revenues for the twelve months ending March 31, 2023 was $653K, a 97.8% decline year-over-year.
  • Elicio Therapeutics, Inc. annual Revenues for 2022 was $2.3M, a 91.9% decline from 2021.
  • Elicio Therapeutics, Inc. annual Revenues for 2021 was $28.3M, a 883% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.3M -$26M -91.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-17
2021 $28.3M +$25.4M +883% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $2.88M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.